Liu et al. verified the cancer-promoting role of GPRC5A in PaCa and found that when GPRC5A was knocked out, the inactivated phosphorylation of GSK-3β (Glycogen synthase kinase-3β) was upregulated 35. Here, GSK3B is linked to cancer.